
In a comprehensive study comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) for critical aortic stenosis, researchers conducted a meta-analysis of eight trials involving 8898 patients. Both groups exhibited improved quality of life (QoL) and functional outcomes one month post-procedure. TAVI demonstrated significantly superior QoL improvements at one month compared to SAVR. However, no significant differences were observed between the two procedures at one year. These findings emphasize the short-term advantages of TAVI in enhancing patients' lives and highlight crucial considerations for shared decision-making in aortic stenosis treatment.
Like
Save
Share